FDA Broadens Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Issues

Esperion (NASDAQ: ESPR) announced today that the FDA has approved expanded labels for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets. This approval is based on positive CLEAR Outcomes data and includes indications for cardiovascular risk reduction…

Read MoreFDA Broadens Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Issues

Spectrum Solutions® Unveil Simply PERIO™ Saliva Test with Simply Test® Power

Spectrum Solutions®, a leading saliva diagnostic biotech company, has launched SimplyPERIO™, a new saliva diagnostic testing solution. This innovative test addresses the growing focus on the mouth-body connection and its impact on overall health. SimplyPERIO™ offers comprehensive health insights by…

Read MoreSpectrum Solutions® Unveil Simply PERIO™ Saliva Test with Simply Test® Power